The clinical spectrum of phosphomannomutase 2 deficiency (CDG-Ia)
- 1 September 2009
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1792 (9) , 827-834
Abstract
No abstract availableKeywords
This publication has 119 references indexed in Scilit:
- Different neuroradiological findings during two stroke-like episodes in a patient with a congenital disorder of glycosylation type IaBrain and Development, 2009
- Transferrin hypoglycosylation in hereditary fructose intolerance: Using the clues and avoiding the pitfallsJournal of Inherited Metabolic Disease, 2007
- Congenital disorder of glycosylation type Ia presenting with hydrops fetalisJournal of Medical Genetics, 2007
- Targeted Disruption of the Mouse Phosphomannomutase 2 Gene Causes Early Embryonic LethalityMolecular and Cellular Biology, 2006
- Skeletal Dysplasia and Myelopathy in Congenital Disorder of Glycosylation Type IAThe Journal of Pediatrics, 2006
- Underdiagnosis of mild congenital disorders of glycosylation type IaPediatric Neurology, 2004
- Congenital disorders of glycosylation type I leads to altered processing of N-linked glycans, as well as underglycosylationBiochemical Journal, 2001
- Failure to diagnose carbohydrate-deficient glycoprotein syndrome prenatallyPediatric Neurology, 1994
- Carbohydrate-deficient glycoprotein syndromes: Peculiar group of new disordersPediatric Neurology, 1993
- Early manifestations of the carbohydrate-deficient glycoprotein syndromeThe Journal of Pediatrics, 1993